the outcomes of patients with primary refractory and relapsed acute leukemia
Published 2 years ago • 51 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
8:57
outcomes of sct in t-all and t-lbl
-
3:23
patient characteristics and outcomes of allosct for bpdcn
-
1:08
outcomes of patients with triple-class refractory myeloma: a single-center retrospective study
-
3:36
the long-term outcomes of consolidative allosct for bpdcn
-
3:16
developing patient-specific mrd markers for predicting and preventing mds relapse post-sct
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:06
managing relapsed all: the role of novel cellular therapies & importance of conditioning regimens
-
1:34
single-center study evaluating the outcomes of patients with aml who relapsed after allosct
-
14:44
the role of allosct in patients with hl who relapse after autosct and the impact of novel agents
-
1:46:07
hematology lecture
-
10:34
remission induction therapy prior to allosct in aml: insights from the asap trial
-
2:09
the importance of involving patients in research
-
1:28
use of machine learning to predict outcomes for patients with scd
-
0:50
management of variant acute promyelocytic leukemia
-
2:45
continuity of care for patients with hematological predispositions to aml
-
2:41
an overview of the latest advances in hematology
-
1:13
outcomes following fd & nfd related donor haplo transplantation for patients with acute leukemias
-
3:26
survival trends for patients with relapsed ph all after allo-hsct
-
1:59
the optec study: evaluating outpatient step-up administration of teclistamab in pts with r/r myeloma
-
1:56
treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
-
1:03
late effect surveillance following allosct: the publication of new guidelines
-
3:56
phase i study of tinostamustine in pre-treated patients with r/r hodgkin lymphoma